Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice
Author(s) -
Chandraiah Godugu,
Swarna Bale,
Manoj Sunkoju,
ShivaShankar Reddy,
Veerabhadra Swamy
Publication year - 2016
Publication title -
indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.194859
Subject(s) - bleomycin , masson's trichrome stain , bronchoalveolar lavage , hydroxyproline , histopathology , pulmonary fibrosis , pathology , medicine , western blot , lung , fibrosis , malondialdehyde , oxidative stress , chemistry , biochemistry , chemotherapy , gene
Pulmonary fibrosis (PF) is a progressive and predominantly lethal form of several interstitial lung diseases with limited current therapeutics; it is, therefore, essential to develop a simple, homogeneous, and noninvasive disease model to investigate possible anti-fibrotic approaches. The present study is designed to develop oropharyngeal aspiration (OPA) model of bleomycin (BLM)-induced PF as a simple and alternative to intratracheal (IT) administration of BLM in Swiss mice strain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom